Biology of advanced uveal melanoma and next steps for clinical therapeutics. Read more about Biology of advanced uveal melanoma and next steps for clinical therapeutics.
In melanoma, Hippo signaling is affected by copy number alterations and YAP1 overexpression impairs patient survival. Read more about In melanoma, Hippo signaling is affected by copy number alterations and YAP1 overexpression impairs patient survival.
Sporadic naturally occurring melanoma in dogs as a preclinical model for human melanoma. Read more about Sporadic naturally occurring melanoma in dogs as a preclinical model for human melanoma.
Recurrent BRAF kinase fusions in melanocytic tumors offer an opportunity for targeted therapy. Read more about Recurrent BRAF kinase fusions in melanocytic tumors offer an opportunity for targeted therapy.
Genomic characterisation of acral melanoma cell lines. Read more about Genomic characterisation of acral melanoma cell lines.
Genetic and molecular characterization of uveal melanoma cell lines. Read more about Genetic and molecular characterization of uveal melanoma cell lines.
The melanomas: a synthesis of epidemiological, clinical, histopathological, genetic, and biological aspects, supporting distinct subtypes, causal pathways, and cells of origin. Read more about The melanomas: a synthesis of epidemiological, clinical, histopathological, genetic, and biological aspects, supporting distinct subtypes, causal pathways, and cells of origin.
BRAF mutations in cutaneous melanoma are independently associated with age, anatomic site of the primary tumor, and the degree of solar elastosis at the primary tumor site. Read more about BRAF mutations in cutaneous melanoma are independently associated with age, anatomic site of the primary tumor, and the degree of solar elastosis at the primary tumor site.
Regulation of NR4A nuclear receptor expression by oncogenic BRAF in melanoma cells. Read more about Regulation of NR4A nuclear receptor expression by oncogenic BRAF in melanoma cells.
